Triglycerides and HDL Cholesterol
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 56 of the 59 references it cites were found in a registry or an index.
Abstract
Diabetes carries a high risk of atherosclerosis, and cardiovascular disease, especially coronary heart disease (CHD) and stroke, is by far the leading cause of death among patients with type 2 diabetes. Although statins reduce the risk of major vascular events by about one-fifth per millimole per liter reduction in LDL cholesterol, with similar proportional reductions in major coronary events, stroke, and the need for coronary revascularization, the residual risk remains high. In the Scandinavian Simvastatin Survival Study (4S) (1), although the relative risk reduction in diabetic patients was larger than in nondiabetic patients, simvastatin-treated diabetic patients were still at higher risk of death than the placebo-treated nondiabetic patients. Multifactorial intervention reduces the risk even further, but significant danger remains. Current guidelines call for an aggressive treatment strategy to reduce LDL cholesterol, blood pressure, and glucose levels in diabetic patients, but data concerning the management of high triglyceride (TG) levels and low HDL cholesterol levels remains inconclusive. This article reviews the data concerning diabetic dyslipidemia and its management. DIABETIC DYSLIPIDEMIA — The cluster of lipid abnormalities associated with type 2 diabetes is defined by a high concentration of TG and small dense LDL and a low concentration of HDL cholesterol. Plasma LDL cholesterol levels are generally normal. Insulin resistance is believed to contribute to this atherogenic dyslipidemia by increasing the hepatic secretion of VLDL and other apolipoprotein (apo)B-containing lipoprotein particles,
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Obesity has a clear correlation with the incidence of cardiovascular disorders including hypertension, coronary artery disease, heart failure and sudden death”
In the citing paper
“many patients with insulin resistance, the main etiology of T2DM, tend to have high triglyceride and low HDL levels [53,54,55]”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Colhoun, H. M., Betteridge, D. J., Durrington, P. N., Hitman, G. A., W Neil, H. A., Livingstone, S. J., Thomason, M. J., Mackness, M. I., Charlton-Menys, V., & Fuller, J. H. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16895-5 · Cited by 3,755
Effects of torcetrapib in patients at high risk for coronary events
Barter, P. J., Caulfield, M., Eriksson, M., Grundy, S. M., Kastelein, J. J. P., Komajda, M., Lopez-Sendon, J., Mosca, L., Tardif, J.-C., Waters, D. D., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706628 · Cited by 3,139 · cited 1×
“FUTURE PROSPECTS — The concept of cholesterol ester transfer protein (CETP) inhibition suffered a serious blow when the results of the ILLUMINATE trial demonstrated an increase in adverse events in patients treated with torcetrapib (42).”
BackgroundYokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Saito, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60527-3 · Cited by 2,516
Nordestgaard, B. G., Benn, M., Schnohr, P., & Tybjærg-Hansen, A. (2007) · JAMA · doi:10.1001/jama.298.3.299 · Cited by 2,058
Brown, B. G., Zhao, X.-Q., Chait, A., Fisher, L. D., Cheung, M. C., Morse, J. S., Dowdy, A. A., Marino, E. K., Bolson, E. L., Alaupovic, P., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011090 · Cited by 1,979 · cited 2×
“The simvastatin-niacin combination was also associated with a 90% reduction in the composite end point of major cardiovascular events (32).”
BackgroundFifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin
Canner, P. L., Berge, K. G., Wenger, N. K., Stamler, J., Friedman, L., Prineas, R. J., & Friedewald, W. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80293-5 · Cited by 1,824 · cited 1×
“In the Coronary Drug Project, niacin reduced mortality among myocardial infarction survivors, although, contrary to the relatively rapid effect of statins, mortality rates were almost identical throughout the first 68 months of follow-up and did not begin to diverge until month 72 (31).”
ResultNissen, S. E., Tsunoda, T., Tuzcu, E. M., Schoenhagen, P., Cooper, C. J., Yasin, M., Eaton, G. M., Lauer, M. A., Sheldon, W. S., Grines, C. L., et al. (2003) · JAMA · doi:10.1001/jama.290.17.2292 · Cited by 1,707 · cited 1×
“In one small study, intravenous recombinant apoA-I Milano/phospholipid complexes produced regression of coronary atherosclerosis as measured by intravascular ultrasound (44).”
BackgroundHokanson, J. E., & Austin, M. A. (1996) · Journal of Cardiovascular Risk · doi:10.1097/00043798-199604000-00014 · Cited by 1,706 · cited 1×
“In a meta-analysis of 17 population-based prospective studies, increased plasma TG levels were associated with increased coronary disease risk in both men and women, after adjustment for HDL cholesterol and other risk factors (7).”
Pyörälä, K., Pedersen, T. R., Kjekshus, J., Faergeman, O., Olsson, A. G., Thorgeirsson, G., & The Scandinavian Simvastatin Survival Study (4S) Group (1997) · Diabetes Care · doi:10.2337/diacare.20.4.614 · Cited by 1,623
Cited by
Ozder, A. (2014) · Lipids in Health and Disease · doi:10.1186/1476-511x-13-183 · Cited by 187
Choi, Y. J., Jeon, S.-M., & Shin, S. (2020) · Nutrients · doi:10.3390/nu12072005 · Cited by 193
“Obesity has a clear correlation with the incidence of cardiovascular disorders including hypertension, coronary artery disease, heart failure and sudden death, and many patients with insulin resistance, the main etiology of T2DM, tend to have high triglyceride and low HDL levels [53–55].”
Obesity and its impact on female reproductive health: unraveling the connections
Zheng, L., Yang, L., Guo, Z., Yao, N., Zhang, S., & Pu, P. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1326546 · Cited by 209
“Elevated triglycerides, reduced high-density lipoprotein-cholesterol (HDL-C) levels, and a general dyslipidemic state have implications not only for cardiovascular health but also for reproductive outcomes (50).”
BackgroundChen, Y. Q., Pottanat, T. G., Siegel, R. W., Ehsani, M., Qian, Y.-W., Zhen, E. Y., Regmi, A., Roell, W. C., Guo, H., Luo, M. J., et al. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra120000781 · Cited by 147
Chaudhary, R., Likidlilid, A., Peerapatdit, T., Tresukosol, D., Srisuma, S., Ratanamaneechat, S., & Sriratanasathavorn, C. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-36 · Cited by 135
A systematic review of metabolite profiling in gestational diabetes mellitus
Huynh, J., Xiong, G. X., & Bentley–Lewis, R. (2014) · Diabetologia · doi:10.1007/s00125-014-3371-0 · Cited by 113
Sheng, G., Kuang, M., Yang, R., Zhong, Y., Zhang, S., & Zou, Y. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03470-z · Cited by 96
Dietary Interventions for Type 2 Diabetes: How Millet Comes to Help
Kam, J., Puranik, S., Yadav, R., Manwaring, H. R., Pierre, S., Srivastava, R. K., & Yadav, R. S. (2016) · Frontiers in Plant Science · doi:10.3389/fpls.2016.01454 · Cited by 101
Olive Oil Nutraceuticals in the Prevention and Management of Diabetes: From Molecules to Lifestyle
AlKhatib, A. H., Tsang, C., & Tuomilehto, J. O. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19072024 · Cited by 90
Li, M., Zhang, W., Zhang, M., Li, L., Wang, D., Yan, G., Qiao, Y., & Tang, C. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-023-02103-z · Cited by 82
“2 Forest plot of multivariate logistic regression analysis based on the quartile of untraditional lipid parameters in Model 3 [26, 27].”
MethodCardiovascular organ damage in type 2 diabetes mellitus: the role of lipids and inflammation
Kozàkovà, M., Morizzo, C., Gonçalves, I., Natali, A., Nilsson, J. Å., & Palombo, C. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0865-6 · Cited by 77
Pei, J., Umapathy, V. R., Vengadassalapathy, S., Hussain, S. F. J., Rajagopal, P., Jayaraman, S., Veeraraghavan, V. P., Palanisamy, C. P., & Gopinath, K. (2022) · Nutrients · doi:10.3390/nu14142932 · Cited by 91
Machine Learning as a Support for the Diagnosis of Type 2 Diabetes
Agliata, A., Giordano, D., Bardozzo, F., Bottiglieri, S., Facchiano, A. M., & Tagliaferri, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076775 · Cited by 82
Park, E., Edirisinghe, I., & Burton‐Freeman, B. M. (2018) · Nutrients · doi:10.3390/nu10091287 · Cited by 74
Halima, B. H., Sonia, G., Sarra, K., Houda, B. J., Fethi, B. S., & Abdallah, A. (2018) · Journal of Medicinal Food · doi:10.1089/jmf.2017.0039 · Cited by 60
Kajikawa, M., Maruhashi, T., Matsumoto, T., Iwamoto, Y., Iwamoto, A., Oda, N., Kishimoto, S., Matsui, S., Aibara, Y., Hidaka, T., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.03.035 · Cited by 60
“with lipid profile, especially HDL-C [21,22,32].”
Dona, A. C., Coffey, S., & Figtree, G. A. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316645469 · Cited by 60
Prevalence of metabolic syndrome in adolescents living in Mthatha, South Africa
Sekokotla, M. A., Goswami, N., Sewani-Rusike, C. R., Iputo, J. E., & Nkeh-Chungag, B. N. (2017) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s124291 · Cited by 62
Marincic, P. Z., Salazar, M. V., Hardin, A., Scott, S., Fan, S. X., Gaillard, P. R., Wyatt, C., Watson, L., Green, P., Glover, P., et al. (2019) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2018.06.303 · Cited by 51
Sone, H., Tanaka, S., Tanaka, S., Iimuro, S., Ishibashi, S., Oikawa, S., Shimano, H., Katayama, S., Ohashi, Y., Akanuma, Y., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1412 · Cited by 57
Tian, J., Wu, X., Zhang, M., Zhou, Z., & Liu, Y. (2017) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2017.1313851 · Cited by 53
Sukkriang, N., Chanprasertpinyo, W., Wattanapisit, A., Punsawad, C., Thamrongrat, N., & Sangpoom, S. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e06264 · Cited by 53
Prediction of type 2 diabetes mellitus onset using logistic regression-based scorecards
Edlitz, Y., & Segal, E. (2022) · eLife · doi:10.7554/elife.71862 · Cited by 48
“444 (Meijnikman et al., 2018; Kontush and Chapman, 2008; Bitzur et al., 2009) was found to be inversely correlated 445 to the predicted probability of T2D onset.”
BackgroundMiselli, M.-A., Nora, E. D., Passaro, A., Tomasi, F., & Zuliani, G. (2014) · Cardiovascular Diabetology · doi:10.1186/s12933-014-0135-6 · Cited by 45
Tran, N. L., Barraj, L., Heilman, J., & Scrafford, C. (2014) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s58668 · Cited by 44
Luo, W., Zhang, J., Xu, D., Zhou, Y., Qu, Z., Yang, Q., & Lv, Q. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1092031 · Cited by 44
Automatic Analysis of Microaneurysms Turnover to Diagnose the Progression of Diabetic Retinopathy
Xu, J., Zhang, X., Chen, H., Li, J., Zhang, J., Shao, L., & Wang, G. (2018) · IEEE Access · doi:10.1109/access.2018.2808160 · Cited by 40
Parent-of-Origin inference for biobanks
Hofmeister, R. J., Rubinacci, S., Ribeiro, D. M., Buil, A., Kutalik, Z., & Delaneau, O. (2022) · Nature Communications · doi:10.1038/s41467-022-34383-6 · Cited by 43
Bever, A. M., Mumford, S. L., Schisterman, E. F., Sjaarda, L. A., Perkins, N. J., Gerlanc, N., DeVilbiss, E. A., Silver, R. M., Kim, K., Nobles, C. J., et al. (2020) · Scientific Reports · doi:10.1038/s41598-019-57373-z · Cited by 39
Proposed mechanisms of Terminalia catappa in hyperglycaemia and associated diabetic complications
Behl, T., & Kotwani, A. (2016) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12676 · Cited by 35
“Similar to in-vitro (lymphocytes culture) and in-vivo (bone marrow cells of Albino mice) carcinogenic and mutagenic models, diabetesinduced dyslipidaemia is also characterized by abnormally high levels of triglycerides (due to increased lipolysis), along with high LDL cholesterol and low HDL cholesterol concentrations…”
BackgroundAssociation Analysis of Genetic Variants with Type 2 Diabetes in a Mongolian Population in China
Bai, H., Liu, H., Suyalatu, S., Guo, X., Chu, S., Chen, Y., Lan, T., Borjigin, B., Orlov, Y. L., Posukh, O. L., et al. (2015) · Journal of Diabetes Research · doi:10.1155/2015/613236 · Cited by 36
Cooper, D. L., Murrell, D. E., Roane, D. S., & Harirforoosh, S. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.05.024 · Cited by 37
Odenkirk, M. T., Stratton, K. G., Gritsenko, M. A., Bramer, L., Webb‐Robertson, B., Bloodsworth, K., Weitz, K., Lipton, A. K., Monroe, M. E., Ash, J. R., et al. (2020) · Molecular Omics · doi:10.1039/d0mo00074d · Cited by 34
Senadheera, S. P. A. S., Ekanayake, S., & Wanigatunge, C. A. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-015-0935-6 · Cited by 34
“Insulin resistance elevates the VLDL and apolipoprotein (apo) Bcontaining lipoproteins concurrently diminishing the suppressive effect of insulin on apo B secretion either by reducing apoB degradation or by inhibition of microsomal TG transfer protein activity [19].”
BackgroundLee, M. W., Park, J. K., Hong, J. W., Kim, K. J., Shin, D. Y., Ahn, C. W., Song, Y. D., Cho, H. K., Park, S. W., & Lee, E. J. (2013) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2013.37.3.207 · Cited by 34
Evaluation of antioxidant and anti-hypercholesterolemic potential of Vitis vinifera leaves
Devi, S., & Singh, R. (2017) · Food Science and Human Wellness · doi:10.1016/j.fshw.2017.07.002 · Cited by 31
Chinese Olive (Canarium album L.) Fruit Extract Attenuates Metabolic Dysfunction in Diabetic Rats
Yeh, Y., Chiang, A., & Hsieh, S. (2017) · Nutrients · doi:10.3390/nu9101123 · Cited by 32
“Accumulating evidence indicates that obesity contributes to down-regulation of insulin secretion, defecting insulin action or both [3,4], which may disturb carbohydrate and lipid homeostasis [5].”
BackgroundRaj, R., Bhatti, J. S., Badada, S. K., & Ramteke, P. W. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2630 · Cited by 31
Li, B., Liu, Y., Zhou, X. J., Chen, L., Yan, L., Tang, X., Gao, Z., Wan, Q., Luo, Z., Qin, G., et al. (2024) · Journal of Diabetes · doi:10.1111/1753-0407.13592 · Cited by 33
“24,25 TG and HDL-C were repeatedly demonstrated as being connected with diabetes and pre-diabetes previously, 17,26,27 but some controversies exist regarding the relationship of LDL-C, TC and hyperglycemia.”
BackgroundKajikawa, M., Maruhashi, T., Kishimoto, S., Matsui, S., Hashimoto, H., Takaeko, Y., Yusoff, F. M., Kihara, Y., Chayama, K., Goto, C., et al. (2019) · Circulation Journal · doi:10.1253/circj.cj-18-1082 · Cited by 29
Relationship of pentraxin 3 with insulin sensitivity in gestational diabetes
Todoric, J., Handisurya, A., Knapp, B., Tura, A., Pacini, G., & Kautzky‐Willer, A. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12051 · Cited by 25
Njike, V. Y., Ayettey, R. G., Rajebi, H., Treu, J. A., & Katz, D. L. (2016) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000281 · Cited by 25
Fitzmorris, P. S., Colantonio, L. D., Perez, E. G. T., Smith, I. B., Kakati, D., & Malik, T. A. (2015) · Digestion · doi:10.1159/000380763 · Cited by 25
Lee, M.-K., Han, K., Kim, M. K., Koh, E. S., Kim, E. S., Nam, G. E., Hong, O., Kim, B., & Kwon, H. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108237 · Cited by 24
Yadav, C. B., Srivastava, R. K., Beynon, S., Englyst, K. N., Gangashetty, P. I., & Yadav, R. S. (2021) · Food and Energy Security · doi:10.1002/fes3.341 · Cited by 24
“Replacing available carbohydrate in the meal with SDS and RS, therefore, reduces postprandial glycaemia helping patients especially with T2D to normalize the glucose pressure.”
BackgroundInfluentialChapman, A., Browning, C. J., Enticott, J., Yang, H. M., Liu, S., Zhang, T., & Thomas, S. A. (2018) · Frontiers in Public Health · doi:10.3389/fpubh.2018.00252 · Cited by 27
“However, the objectivity of triglyceride levels as a clinically relevant outcome is debatable (28); and the clinical significance of systolic BP improvements <140 mmHg is unclear (29).”
BackgroundThe effects of simvastatin treatment on plasma lipid-related biomarkers in men with dyslipidaemia
Chen, F., Maridakis, V., O’Neill, E. A., Hubbard, B. K., Strack, A. M., Beals, C. R., Herman, G. A., & Wong, P. (2011) · Biomarkers · doi:10.3109/1354750x.2011.561367 · Cited by 23
“…several broad classes of easily quantitated lipids, such as triglycerides (TG) and cholesterol, are associated with diseased states like diabetes (Bitzur et al., 2009), coronary artery disease (Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection,…”
BackgroundAbi-Ayad, M., Abbou, A., Abi-Ayad, F. Z., Behadada, O., & Benyoucef, M. (2017) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2017.12.017 · Cited by 24
Possible association between ABCC8 C49620T polymorphism and type 2 diabetes in a Nigerian population
Engwa, G. A., Nwalo, F. N., Chikezie, C. C., Onyia, C. O., Ojo, O. O., Mbacham, W. F., & Ubi, B. E. (2018) · BMC Medical Genetics · doi:10.1186/s12881-018-0601-1 · Cited by 24
Koo, B. K., Park, S. H., Han, K., & Moon, M. K. (2021) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2021.10.1.88 · Cited by 20
Pantophlet, A. J., Gilbert, M. S., van den Borne, J. J. G. C., Gerrits, W. J. J., Roelofsen, H., Priebe, M. G., & Vonk, R. J. (2016) · Journal of Dairy Science · doi:10.3168/jds.2015-10277 · Cited by 21
Pantophlet, A. J., Gerrits, W. J. J., Vonk, R. J., & van den Borne, J. J. G. C. (2016) · Journal of Dairy Science · doi:10.3168/jds.2016-11524 · Cited by 20
“In humans, the triglyceride/HDLcholesterol ratio is used to characterize dyslipidemia, which is associated with insulin resistance (Li et al., 2008; Bitzur et al., 2009).”
The Hidden Burden of Diabetes Mellitus in an Urban Community of Southwest Ethiopia
Yunka, T. T., Mogas, S. B., Zawdie, B., Tamiru, D., Tesfaye, Y., Kebede, A., Tadesse, M., Gudina, E. K., & Dadi, L. S. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s269386 · Cited by 18
Murillo, A. L., Li, J. X., & Castillo‐Chávez, C. (2019) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2019288 · Cited by 19
“Since TG is associated with cardiovascular diseases [13], then high TG levels coexisting with normal or impaired fasting glucose further increase risk of metabolic-related diseases, such as T2DM.”
BackgroundBai, X., Jia, J., Kang, Q., Fu, Y., Zhou, Y., Zhong, Y., Zhang, C., & Li, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.605979 · Cited by 22
“Similarly, knocking out GCGR and treatment with GCGR antagonist (LY2409021) induced liver fat accumulation in zebrafish and patients with type 2 diabetes (T2D), respectively (Guzman et al., 2017; Kang et al., 2020).”
BackgroundThe nucleotide hydrolysis is altered in blood serum of streptozotocin-induced diabetic rats
Rücker, B., Abreu-Vieira, G., Bischoff, L. B., Harthmann, Â. D., Sarkis, J. J. F., Wink, M. R., & Casali, É. A. (2010) · Archives of Physiology and Biochemistry · doi:10.3109/13813451003777067 · Cited by 16
“The increase in glucose concentration in diabetes is followed by a change in the lipid profile in the serum (Bitzur et al., 2009).”
BackgroundDiabetes in Patients With Pancreatic Neuroendocrine Neoplasms
Zhuge, X., Wang, Y., Chen, X., & Guo, C. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.615082 · Cited by 16
“Lipid abnormalities, such as high TG and a low concentration of HDL, are also associated with DM (25).”
BackgroundAntioxidant and Anti-Hypercholesterolemic Potential of Vitis vinifera Leaves
Devi, S., & Singh, R. (2017) · Pharmacognosy Journal · doi:10.5530/pj.2017.4.90 · Cited by 16
Hossein-Nia, B., Khorram, S., Rezazadeh, H., Safaeian, A., Ghiasi, R., & Tarighat‐Esfanjani, A. (2018) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2018.025 · Cited by 16
“The lipid abnormalities related to DM include high concentration of total cholesterol (TC) and triglyceride (TG) levels.(4) Besides, reduction in serum levels of high density lipoprotein cholesterol (HDL-C) was observed in diabetic patients.”
BackgroundHasan, M. N., Sabrin, F., Rokeya, B., Khan, M. S. H., Ahmed, M. U., Matondo, A., Billah, M. M., & Akter, S. (2019) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-019-2667-5 · Cited by 15
Kirk, I. K., Simon, C., Banasik, K., Holm, P. C., Haue, A. D., Jensen, P. B., Jensen, L. J., Rodríguez, C. L., Pedersen, M. K., Eriksson, R., et al. (2019) · eLife · doi:10.7554/elife.44941 · Cited by 15
“Known risk factors for complications include age, diabetes duration, polypharmacy, comorbidities (Juarez et al., 2012), increased levels of circulating triglyceride and LDL-cholesterol, and lower levels of HDL-cholesterol (Saudek et al., 2006; Giannini et al., 2011; Bitzur et al., 2009).”
Association between cardiometabolic index and female infertility: A population-based study
Kong, L., Xian, D., Wang, Q., Xie, R., Sun, F., Zhou, N., Li, C., Chen, X., & Qian, H. (2024) · PLoS ONE · doi:10.1371/journal.pone.0313576 · Cited by 14
Husni, A., Pawestri, S., & Isnansetyo, A. (2016) · Jurnal Teknologi · doi:10.11113/jt.v78.8145 · Cited by 20
High prevalence of metabolic syndrome in an elderly Croatian population – a multicentre study
Pašalić, D., Dodig, S., Čorović, N., Pizent, A., Jurasović, J., & Pavlović, M. (2010) · Public Health Nutrition · doi:10.1017/s1368980010003265 · Cited by 14
Park, J., Kim, D. H., Lee, H., Lee, H., Hwang, I., Yoon, Y. E., Park, H. E., Lee, S., Choi, S., Kim, Y.-J., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.020050 · Cited by 14
Predicting progression patterns of type 2 diabetes using multi-sensor measurements
Ramazi, R., Perndorfer, C., Soriano, E. C., Laurenceau, J., & Beheshti, R. (2021) · Smart Health · doi:10.1016/j.smhl.2021.100206 · Cited by 17
Association of fasting plasma glucose and serum lipids in Type 2 diabetics
Kuvalekar, A., Khadke, S. P., Harke, S., Ghadge, A. A., Kulkarni, O. P., Bhalerao, S. S., Diwan, A. G., & Pankaj, M. (2015) · Indian Journal of Pharmaceutical Sciences · doi:10.4103/0250-474x.169033 · Cited by 14
Lipid Complications after Hematopoietic Stem Cell Transplantation (HSCT) in Pediatric Patients
Bis, G., Szlasa, W., Sondaj, K., Zendran, I., Mielcarek‐Siedziuk, M., & Barg, E. (2020) · Nutrients · doi:10.3390/nu12092500 · Cited by 15
Prevalence of and Risk Factors for Prediabetes in Patients Infected With HIV
Arafath, S., Campbell, T., Yusuff, J., & Sharma, R. (2018) · Diabetes Spectrum · doi:10.2337/ds17-0009 · Cited by 13
Njike, V. Y., Treu, J. A., Kela, G., Ayettey, R. G., Comerford, B. P., & Siddiqui, W. T. (2021) · Journal of Nutrition · doi:10.1093/jn/nxab283 · Cited by 13
Ojewale, A. O., Mada, S. B., Oyebadejo, S. A., Afodun, A. M., Aladeyelu, O. S., & Kolawole, B. (2020) · BioMed Research International · doi:10.1155/2020/3189672 · Cited by 14
“occurrence of a high concentration of triglycerides (TGs), low concentration of high-density lipoprotein (HDL), and small dense low-density lipoprotein (LDL), and plasma cholesterol levels is generally expected [2].”
Mokale, S. N., Nevase, M. C., Sakle, N. S., Dube, P. N., Shelke, V. R., Bhavale, S. A., & Begum, A. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.03.030 · Cited by 12
Antioxidant and Anti-hypercholesterolemic potential of Vitis vinifera leaves
Devi, S., & Singh, R. (2017) · Pharmacognosy Journal · doi:10.5530/pj.2017.6.126 · Cited by 12
Nwosu, B. U., Parajuli, S., Khatri, K., Jasmin, G., Al‐Halbouni, L., & Lee, A. F. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.705565 · Cited by 11
“The major link between diabetes mellitus and ASCVD, referred to as diabetic dyslipidemia, occurs in the setting of low high-density lipoprotein cholesterol (HDL-C), high fasting and/or postprandial triglycerides (TG), average to high lowdensity lipoprotein cholesterol (LDL-C), and predominantly small dense LDL particl…”
BackgroundInfluentialThe Theory of Hyperlipidemic Memory of Type 1 Diabetes
Nwosu, B. U. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.819544 · Cited by 11
“Elevated non-HDL-C correlates with 99% increased CVD risk for patients with T2D (17) where the classic lipid abnormalities are characterized by elevated TG, small dense LDL-C, and low HDL-C (18).”
BackgroundLi, B., Liu, Y., Ma, X., & Guo, X. (2025) · Scientific Reports · doi:10.1038/s41598-025-90773-y · Cited by 13
Müller, G. A., Lechner, A., Tschöp, M. H., & Müller, T. D. (2021) · Biomedicines · doi:10.3390/biomedicines9030277 · Cited by 11
Clinacanthus nutans: Its potential against diabetic vascular diseases
Azemi, A. K., Mokhtar, S. S., & Rasool, A. H. G. (2020) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902020000118838 · Cited by 11
“In the diabetic state, levels of free fatty acids are elevated because of their excess liberation from adipose tissue and diminished uptake by skeletal muscle (Boden, 1999; Creager et al., 2003; Kelley, Simoneau, 1994).”
BackgroundCombination of cafeteria diet with intraperitoneally streptozotocin in rats. A type-2 diabetes model
Santos, M. M. R., Cavalcante, A. C. F. P. S., do Amaral, L. A., de Souza, G. H. O., dos Santos, B. S., Portugal, L. C., Bittencourt, F. F., Troquez, T., Rafacho, B. P. M., Hiane, P. A., et al. (2021) · Acta Cirúrgica Brasileira · doi:10.1590/acb360702 · Cited by 11
Lee, M. H., Neeland, I. J., Rocha, N. D. A., Hughes, C., Malloy, C. R., & Jin, E. S. (2021) · Metabolism Open · doi:10.1016/j.metop.2021.100161 · Cited by 11
Interlinkage among cardio-metabolic disease markers in an urban poor setting in Nairobi, Kenya
Haregu, T., Oti, S. O., Ngomi, N. N., Khayeka‐Wandabwa, C., Egondi, T., & Kyobutungi, C. K. (2016) · Global Health Action · doi:10.3402/gha.v9.30626 · Cited by 11
“The mechanisms linking hyperglycemia and hypercholesterolemia have been well described (20, 21).”
NOTUM promotes thermogenic capacity and protects against diet-induced obesity in male mice
Guo, F., Seldin, M. M., Péterfy, M., Charugundla, S., Zhou, Z., Lee, S. D., Mouton, A., Rajbhandari, P., Zhang, W., Pellegrini, M. A., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-95720-1 · Cited by 10
Postmortem evaluation of cholesterol, triglyceride, and apolipoprotein levels
Girard, C., Scarpelli, M. P., Tettamanti, C., & Palmière, C. (2017) · International Journal of Legal Medicine · doi:10.1007/s00414-017-1669-4 · Cited by 10
Dislipidemia diabética, macro y microangiopatía
Pedro‐Botet, J., Benaiges, D., & Pedragosa, À. (2012) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2012.09.005 · Cited by 14
“Un índice trigli-céridos/colesterol HDL elevado se asocia también de forma independiente con la progresión de microalbuminuria 36 .”
Role of microvascular dysfunction in left ventricular dysfunction in type 2 diabetes mellitus
Halabi, A., Nolan, M. T., Potter, E. L., Wright, L. M., Asham, A., & Marwick, T. H. (2021) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.107907 · Cited by 10
Effects of 3,4-Dihydroxyacetophenone on the Hypercholesterolemia-Induced Atherosclerotic Rabbits
Zhang, D., Liu, J., Wang, L., Wang, J., Li, W., Baoxiang, Z., Hou, J.-P., & Liu, T. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b12-00710 · Cited by 8
Biradar, R. A., & Singh, D. P. (2020) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2020.02.001 · Cited by 8
Moritz, C. E. J., Abreu-Vieira, G., Piroli, C., de Senna, P. N., Cardoso, V. V., Wink, M. R., Harthmann, Â. D., Rücker, B., & Casali, É. A. (2012) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2012.697173 · Cited by 7
Aldayel, T. S., Alshammari, G. M., Omar, U. M., Grace, M. H., Lila, M. A., & Yahya, M. A. (2020) · Journal of Taibah University for Science · doi:10.1080/16583655.2020.1855859 · Cited by 10
“Nevertheless, it is well established that the levels of TGs synthesis are inversely proportional to the circulatory levels of HDL-C [65].”
BackgroundInfluentialGuo, H., Ma, C., Wu, X., & Pan, C. (2021) · International Journal of Endocrinology · doi:10.1155/2021/9976067 · Cited by 7
Genetic variants at 10q23.33 are associated with plasma lipid levels in a Chinese population
Sijun, L., Qian, Y., Lu, F., Meihua, D., Yu-di, L., Li, H., Shen, C., Dai, J., Yue, J., Guangfu, J., et al. (2014) · Journal of Biomedical Research · doi:10.7555/jbr.27.20120091 · Cited by 7
Netter, U., Bisht, V., Gaurav, A., Sharma, R., Ghosh, A., Bisht, V. S., Ambatipudi, K., Sharma, H. P., Mohanty, S., Loat, S., et al. (2025) · The FEBS Journal · doi:10.1111/febs.70131 · Cited by 6
Gupta, R., Kapoor, B., Kaur, G., & Gupta, M. (2017) · Journal of Advanced Pharmaceutical Technology amp Research · doi:10.4103/japtr.japtr_69_17 · Cited by 6
“[5] This reduction in blood glucose level can be correlated with the decreased level of triglyceride in intermediate and high dose groups.[25]”
BackgroundRodrigues, W. J., Bhagya, N., & Chandrashekar, K. R. (2020) · Synergy · doi:10.1016/j.synres.2020.100064 · Cited by 5
Liu, J., Wang, L., Qian, Y., Dai, J., Shen, C., Jin, G., Hu, Z., & Shen, H. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.02.039 · Cited by 5
Sphingolipidomic profile and HDL subfractions in obese dyslipidemic type 2 diabetic patients
Aslan, İ., Aydın, D., Koca, Y., Yılmaz, Ç., Çeker, T., Öztüzün, A., & Aslan, M. (2023) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2023.106719 · Cited by 5
Warjri, D. S. A. P. (2013) · International Journal of Pharma and Bio Sciences · Cited by 5
Elrherabi, A., Nasr, F. A., Farihi, A., Bouhrim, M., Loukili, E. H., Driouech, M., Daoudi, N. E., Al-Zharani, M. M., Qurtam, A. A., & Bnouham, M. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.70469 · Cited by 4
Metabolic Syndrome: Consensus and Controversy: State of the Art
Tavares, H. D. P., Gelaleti, R. B., Picolo, F., Tavares, S. B. M. P., Marini, G., Abbade, J. F., dos Santos, D. C. D. M., Campos, P. A. D., Calderon, I. D. M. P. [., & Rudge, M. V. C. (2015) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2015.59016 · Cited by 6
“In short the risk factors for metabolic syndrome are: less physical exercise; Poor diet; Abdominal obesity; dyslipidemia; Dysglycemia and Tabagismo [28].”
Domingo, M. G., Kurtz, M., Maglione, G. A., Martín, M., Brites, F. D., Tasat, D. R., & Olmedo, D. G. (2024) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.35443 · Cited by 4
Metadata
- Authors
- Bitzur, R., Cohen, H., Kamari, Y., Shaish, A., & Harats, D.
- Affiliations
- Sheba Medical Center (IL)
- Corresponding author
- Bitzur, Rafael
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-11-01
- Volume
- 32
- Issue
- suppl_2
- Pages
- S373-S377
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2811435
- OpenAlex
- W2170606689
- Cited by
- 132
- References
- 59
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 9 · 2023: 5 · 2022: 10 · 2021: 16 · 2020: 14 · 2019: 6 · 2018: 10 · 2017: 9 · 2016: 10 · 2015: 9 · 2014: 9 · 2013: 8 · 2012: 5
- FWCI
- 0.59
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- triglycerides, HDL cholesterol, type 2 diabetes, diabetic dyslipidemia, residual cardiovascular risk, statins, small dense LDL, insulin resistance, atherogenic dyslipidemia, cardiovascular disease, lipid control
- MeSH terms
- Cardiovascular Diseases, Coronary Disease, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Humans, Cholesterol, HDL, Niacin, Triglycerides, Fatty Acids, Omega-3, Stroke, PPAR alpha, Diabetes Complications, Dyslipidemias, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.